Trade NYXH stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Nyxoah SA (NYXH) is trading at US$0.81, down 5.63% today as of Nov 5, 16:00 EST. The company has a market capitalisation of US$160.12M. Over the past 52 weeks, NYXH has traded between US$0.80 and US$5.92. On Syfe you can trade NYXH with $0 commission and add it to your watchlist.
| Previous close | US$0.86 |
|---|---|
| Market cap | US$160.12M |
| 52-week range | US$0.80 – US$5.92 |
| Volume | 212.96K |
| Exchange | US |
Nyxoah SA
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
Year: 2021
Nyxoah Names Liam Kelly as Chief Executive
Sep 28, 9:03 PM · MT Newswires
Nyxoah Names Loic Moreau Interim CFO as John Landry Steps Down
Sep 21, 8:33 PM · MT Newswires
CVRx Names New Chief Financial Officer
Sep 21, 8:23 PM · MT Newswires
Nyxoah Implants First Patient in Sleep Apnea Device Study
Sep 8, 8:51 AM · MT Newswires
Nyxoah Shares Jump After Genio Meets Primary Endpoints in CCC Patient Study
Sep 2, 9:48 PM · MT Newswires
Nyxoah SA (NYXH) stock is trading at US$0.81, -5.63% from the previous close of US$0.86.
The market cap for Nyxoah SA (NYXH) stock is approximately US$160.12M.
The 52-week high for Nyxoah SA (NYXH) stock is US$5.92.
The 52-week low for Nyxoah SA (NYXH) stock is US$0.80.
Nyxoah SA (NYXH) does not currently pay a dividend.
Stay on top of NYXH
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
